Cargando…
Risk of valvular heart disease associated with use of fenfluramine
BACKGROUND: Estimates of excess risk of valvular heart disease among prior users of fenfluramine and dexfenfluramine have varied widely. Two major forms of bias appear to contribute to this variability and also result in a systematic under-estimation of risk. The first, a form of nondifferential mis...
Autores principales: | Hopkins, Paul N, Polukoff, Gerald I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194859/ https://www.ncbi.nlm.nih.gov/pubmed/12801402 http://dx.doi.org/10.1186/1471-2261-3-5 |
Ejemplares similares
-
Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
por: Dahl, Charles F, et al.
Publicado: (2008) -
Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023) -
Fenfluramine in the treatment of hypertensive patients with refractory obesity.
por: Scott, M. E., et al.
Publicado: (1975) -
A review of fenfluramine for the treatment of Dravet syndrome patients
por: Simon, Kayla, et al.
Publicado: (2021) -
Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)